Sponser for 13'IFPT
Singleron, established in 2018, has raised $200M to apply single-cell tech across research, diagnostics, health management, and drug development. Operating globally from labs in Nanjing, Suzhou, Germany, the US, and Singapore, it serves 1,200+ clients in 30 countries.More details will be shown on the web page（singleronbio.com）
GeneMind is a high-tech enterprise possessing independent intellectual property rights and key core technologies for gene sequencing instruments. The company focuses on the R&D and manufacturing of upstream equipment and reagents for the gene sequencing industry, providing guardians of life and health with core tools to gain insights into life information—from scientific research to clinical applications.
|
|